Gilead faces lawsuit over HIV drug pricingGilead and other pharma companies stand accused of engaging in a scheme to block cheaper competitors to life-saving Share XGilead faces lawsuit over HIV drug pricinghttps://pharmaphorum.com/news/gilead-faces-lawsuit-over-hiv-drug-pricing/
Teva vows to fight price-fixing lawsuitTeva has said it will defend itself against a lawsuit raised by 44 US states that alleges the Share XTeva vows to fight price-fixing lawsuithttps://pharmaphorum.com/news/teva-vows-to-fight-price-fixing-lawsuit/
Drug firm prosecuted for distributing opioids illegallyA US-based drug distribution company and two former executives are being prosecuted for transporting medicines to pharmacies allegedly Share XDrug firm prosecuted for distributing opioids illegallyhttps://pharmaphorum.com/news/drug-firm-prosecuted-for-distributing-opioids-illegally/
Bayer and J&J settle Xarelto lawsuits in USBayer and Johnson & Johnson have agreed to settle more than 25,000 US lawsuits worth more than $775 Share XBayer and J&J settle Xarelto lawsuits in UShttps://pharmaphorum.com/news/bayer-and-jj-settle-xarelto-lawsuits-in-us/
Celgene gets US patent let-off ahead of BMS mergerShares in Celgene ticked up yesterday after a let-off in a US court case challenging the patents on Share XCelgene gets US patent let-off ahead of BMS mergerhttps://pharmaphorum.com/news/celgene-gets-us-patent-let-off-ahead-of-bms-merger/
Documentaries lift lid on Theranos biotech scamAs criminal fraud investigations continue into former Theranos CEO Elizabeth Holmes and president Ramesh Balwani, further details are Share XDocumentaries lift lid on Theranos biotech scamhttps://pharmaphorum.com/news/documentaries-lift-lid-on-theranos-biotech-scam/
Court backs NHS in hepatitis C procurement row with AbbVieA court has backed NHS England in a case where US pharma giant AbbVie had alleged that its Share XCourt backs NHS in hepatitis C procurement row with AbbViehttps://pharmaphorum.com/news/court-backs-nhs-in-hepatitis-c-procurement-row-with-abbvie/
Pharma stocks fall after new drug price probe in USUS politicians from the resurgent Democratic party have launched a probe into “unsustainable” drug price rises, prompting their Share XPharma stocks fall after new drug price probe in UShttps://pharmaphorum.com/news/pharma-stocks-fall-after-new-drug-price-probe-in-us/
J&J hits back over asbestos in talc claimsShares in Johnson & Johnson slid around 10% on Friday after a Reuters article claimed the company had Share XJ&J hits back over asbestos in talc claimshttps://pharmaphorum.com/news/jj-hits-back-over-asbestos-in-talc-claims/
